In December 2019 China reported numerous cases of pneumonia in Wuhan. The pathogen was soon identified as a novel coronavirus and by mid January a number of whole genome sequences of the pathogen were available in the public domain. This virus was reported to be a RNA virus of 30 K bp and with genetic similarity to virus involved in causing Severe Acute Respiratory Syndrome (SARS) in 2003 and so this virus was named SARS CoV 2 and the disease it caused as Covid 19 [1].

References

1. WHO. Naming the coronavirus disease (Covid-19) and the virus that causes it. Technical Guidance (2020).
2. Corman V., et al. “Diagnostic detection of Wuhan coronavirus 2019 by Real time RT PCR”. Eurosurveillance 25(2020): 2000045
3. Appliedbiosystems. TaqPath Covid-19 Combo kit Catalogue No. A 47814.
4. ICMR Press Release: How India ramped up Covid 19 testing capacity (2020).
5. Gua I., et al. “Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)”. Clinical Infection Disease (2020): 1-8.
6. Bullard J., et al. “Predicting infectious SARS-CoV-2 from diagnostic samples”. Clinical Infection Disease (2020).
7. Wang W., et al. “Detection of SARS-CoV-2 in Different Types of Clinical Specimens”. JAMA 323.18 (2020):1843-1844.
8. Wyllie AL., et al. “Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs”. medRxiv.
9. Srivatsan S., et al. “Preliminary support for a “dry swab, extraction free” protocol for SARS-CoV-2 testing RT-qPCR”. bioRxiv.
10. Kiran U., et al. “Improved and Simplified Diagnosis of Covid-19 using TE Extraction from Dry Swabs”. bioRxiv.
11. Österdahl MF., et al. “Detecting SARS-CoV-2 at point of care: Preliminary data comparing Loop-mediated isothermal amplification (LAMP) to PCR”. medRxiv.
12. Zhang F., et al. “A protocol for detection of COVID-19 using CRISPR diagnostics”. Nature Protocols (2019).
13. Westgard JO., et al. “Covid-19 serology testing strategy: confirm positive results a two test prediction value calculator to assess effectiveness of confirming positive results”. (2020).
14. Tan CW., et al. “A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction”. Nature Biotechnology (2020).
15. Dorward DA., et al. “Tissue-specific tolerance in fatal Covid-19”. medRxiv.
16. Odak I., et al. “Reappearance of effector T cells is associated with recovery from Covid-19”. EBioMedicine (2020).

Citation

Citation: Ashok Rattan. “Laboratory Diagnosis of COVID 19 Infection". Acta Scientific Microbiology 3.10 (2020): 01-03.

Copyright

Copyright: © 2020 Ashok Rattan. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.